{"schema_version":"secwatch.filing_event.v1","accession":"0000037785-26-000139","form_type":"8-K","ticker":"FMC","cik":"0000037785","company_name":"FMC CORP","filed_at":"2026-07-29T20:44:06+00:00","discovered_at":"2026-07-29T20:45:00.703034+00:00","generated_at":"2026-07-29T20:45:07.231121+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"FMC Q2 revenue down 17% to $867M, GAAP loss $1.49/share; lowers full-year guidance","bullets":["Q2 revenue $867M (-17% YoY); GAAP net loss $187M ($1.49 loss per share); adjusted EPS $0.26 (-62%).","Adjusted EBITDA $153M (-26% YoY); cash from ops $363M including $200M rimisoxafen licensing payment.","Full-year 2026 outlook lowered: revenue ex-India $3.50B-$3.70B, Adj. EBITDA $620M-$680M, Adj. EPS $1.19-$1.49.","Strategic actions: India sale ($252M), rimisoxafen licensing ($200M), Newark sale-leaseback ($114M), Tessenderlo equity ($400M) – ~$1B for debt reduction.","Board concludes strategic review; Q3 Adj. EBITDA guided $120M-$140M, Q4 $275M-$315M."],"urls":{"canonical":"https://secwatch.observer/filing/0000037785-26-000139","json":"https://secwatch.observer/filing/0000037785-26-000139.json","markdown":"https://secwatch.observer/filing/0000037785-26-000139.md","text":"https://secwatch.observer/filing/0000037785-26-000139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/37785/000003778526000139/0000037785-26-000139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/37785/000003778526000139/fmc-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T20:45:07.231121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}